Tin tức & Cập nhật
Xem bài viết Nội tiết
Xem
Chỉ hiển thị Multimedia

Glycaemic control in early T2D improved with novel oral GLP-1 receptor agonist
21 Jul 2025
bởiJairia Dela Cruz
For adults with early type 2 diabetes (T2D) not adequately controlled by diet and exercise alone, treatment with the investigational small-molecule, nonpeptide glucagon-like peptide-1 (GLP-1) receptor agonist orforglipron yields significant reductions in glycated haemoglobin levels, according to data from the phase III ACHIEVE-1 trial.
21 Jul 2025

RA onset delayed through 4 years with 1-year abatacept treatment in at-risk individuals
16 Jul 2025
bởiMike Ng
A 12-month therapeutic intervention with self-administered abatacept can delay the onset of rheumatoid arthritis (RA) in at-risk individuals for up to 4 years, according to results from the ALTO follow-up study presented at EULAR 2025.
16 Jul 2025






